# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Dorothea Lange (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML045-SYN-TD
- Date: 1957-04-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gwendolyn Ashford-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review after eight weeks of pacing and physical therapy; zoledronic acid infusion; heartburn back off omeprazole. **S**

## History of present illness

Ms. Lange has had seven weeks of physical therapy, two sessions a week of submaximal strengthening and warm-water exercise with rest days. Her right ankle-foot orthosis was fitted four weeks ago and she uses a cane outdoors. She has had no falls. She now plans each field day with rest breaks and a seat stick, has a colleague carry the tripod, and rests the day after; she is less tired and the evening aching is less. Home overnight oximetry six weeks ago was normal. She completed the eight-week omeprazole trial two weeks ago and stopped it; within five days the heartburn and regurgitation came back on three or four nights a week. She has no difficulty swallowing, weight loss, vomiting, or black stools. She has taken vitamin D3 daily, saw her dentist last month with no problems, and has not yet returned the 24-hour urine collection: she was away photographing for two weeks. **S**

| Element | Detail |
|---|---|
| Interval change | Physical therapy seven weeks; orthosis fitted; no falls; overnight oximetry normal |
| Fatigue | Less with pacing; working two field days a week |
| Heartburn | Returned within five days of stopping omeprazole two weeks ago |
| Bone | Vitamin D taken daily; dental check normal; urine collection not done |
| Today | First zoledronic acid infusion |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired after field days but recovers overnight; weight stable |
| Musculoskeletal | Positive | Milder thigh aching; no new weakness |
| Neurological | Negative | No numbness; no new weakness |
| Respiratory | Negative | No breathlessness |
| Gastrointestinal | Positive | Heartburn and regurgitation three or four nights a week; no difficulty swallowing, vomiting, or black stools |
| Psychiatric | Negative | Mood better; PHQ-9 4 |

6 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (1931 units) by mouth once daily **S**
- Calcium carbonate 500 mg chewable tablet, one or two tablets by mouth as needed for heartburn, no more than six tablets a day, while off omeprazole before the endoscopy **S**
- Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a year **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/76 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 50.6 kg; BMI 21.9 kg/m². All vital signs are synthetic.

25-hydroxyvitamin D: 34 ng/mL; Calcium: 9.4 mg/dL; Creatinine: 0.7 mg/dL; eGFR: 93 mL/min/1.73 m²; PHQ-9: 4; Pain (0 to 10): 5. All results are synthetic.

## Change since baseline

- 25-hydroxyvitamin D: 22 ng/mL (low) at baseline, 34 ng/mL at this visit **S**
- Calcium: 9.3 mg/dL at baseline, 9.4 mg/dL at this visit **S**
- Creatinine: 0.7 mg/dL at baseline, 0.7 mg/dL at this visit **S**
- eGFR: 93 mL/min/1.73 m² at baseline, 93 mL/min/1.73 m² at this visit **S**
- PHQ-9: 6 at baseline, 4 at this visit **S**
- Pain (0 to 10): 6 at baseline, 5 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; walks in with the orthosis and a cane |
| Neurological | Strength unchanged from the baseline: left quadriceps 4/5, right quadriceps 3+/5, right ankle dorsiflexion 2/5 |
| Gait | With the orthosis, no foot drop and less knee hyperextension; Timed Up and Go 11.8 seconds with the orthosis and cane |
| Skin | No pressure marks from the orthosis |
| Abdomen | Soft; mild epigastric tenderness; healed upper abdominal scar |
| Mouth | Teeth and gums in good repair |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-polio syndrome** (G14). Fatigue and pain improving with pacing and non-fatiguing exercise; strength stable; no falls since the orthosis. Pain 5 of 10, from 6. **S**
   - Finish the twelve weeks of physical therapy, then a home program.
   - Continue the field-day pacing plan.
2. **Osteoporosis** (M81.8). Vitamin D 34 ng/mL, calcium 9.4, creatinine 0.7, eGFR 93; dental check normal. Ready for zoledronic acid. The 24-hour urine calcium was not collected; with normal serum calcium, PTH, and phosphate the infusion goes ahead. **S**
   - Zoledronic acid 5 mg intravenously today.
   - She may have fever and aching for a day or two after the first dose; acetaminophen if so.
   - Urine collection rebooked.
3. **Heartburn that returned after stopping omeprazole** (R12). Typical reflux symptoms that responded to omeprazole and returned within days of stopping it. Before committing her to long-term acid suppression, and with an earlier ulcer operation, an upper endoscopy off the proton pump inhibitor will establish the diagnosis and look for esophagitis and Barrett's esophagus. **S**
   - Upper endoscopy in about ten days, three to four weeks after the last omeprazole dose.
   - Calcium carbonate chewable tablets as needed until then.
   - Sedation precautions sent to the endoscopy unit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Manual muscle testing and Timed Up and Go | Every visit | Completed today | Strength unchanged; TUG 11.8 seconds with the orthosis and cane |
| Survey | Pain score | Every visit | Completed today | Pain 5 of 10 |
| Survey | Depression screen (PHQ-9) | Periodically | Completed today | PHQ-9 4 |
| Referral | Supervised non-fatiguing exercise (physical therapy) | Twelve weeks | Up to date | Week seven of twelve; tolerating without next-day exhaustion |
| Examination | Orthosis fit and skin check | Every visit | Completed today | Good fit; no pressure marks |
| Examination | Sleep-disordered breathing screen | At diagnosis and with symptoms | Up to date | Overnight oximetry six weeks ago normal: mean saturation 94 percent, desaturation index 3 per hour |
| Imaging | Spirometry | Yearly or with symptoms | Up to date | Normal eight weeks ago; no breathlessness |
| Examination | Swallowing screen | Every visit | Completed today | No difficulty swallowing |
| Self-management | Energy conservation and pacing | Every visit | Completed today | Two field days a week with rest breaks and a rest day after each |
| Examination | Fall review | Every visit | Completed today | No falls in eight weeks |
| Medication safety | Zoledronic acid: calcium, vitamin D, kidney function, and dental status | Before each infusion | Completed today | Vitamin D 34, calcium 9.4, creatinine 0.7, eGFR 93; dental check last month normal; infusion given |
| Laboratory | 24-hour urine calcium | At diagnosis | Deferred | Missed, a deviation from the secondary-causes protocol: the collection was not done before the infusion because she was away for two weeks. Normal serum calcium, PTH, phosphate, and alkaline phosphatase make hypercalciuria or hyperparathyroidism unlikely, so the infusion went ahead and no harm is expected. Corrective action: kit reissued with a reminder call, to be collected before the yearly review |
| Medication safety | Proton pump inhibitor trial outcome | At 8 weeks | Completed today | Responded; symptoms returned within five days of stopping |
| Imaging | Upper endoscopy off proton pump inhibitor | When symptoms return after stopping, before long-term therapy | Ordered | Booked in about ten days |
| Medication safety | Sedation precautions before the endoscopy | Before any procedure | Completed today | Reduced doses, oxygen and carbon dioxide monitoring, and warming requested |

## Goal progress

- Find the cause of the new weakness and fatigue within four weeks, with other treatable causes excluded. Outcome by 1957-02-25: Post-polio syndrome diagnosed at 16 days after the tests excluded thyroid disease, anemia, diabetes, B12 deficiency, neuropathy, and myopathy. **S**
- No falls over the next six months. In progress; target 1957-08-17. **S**
- Keep working in the field at least two days a week, with planned rests, without exhaustion the next day. In progress; target 1957-12-31. **S**
- Establish the cause of the heartburn and control it on the lowest effective therapy. In progress; target 1957-05-18. **S**
- Replete vitamin D and start fracture-protective treatment. Outcome by 1957-04-20: Vitamin D 34 ng/mL; first zoledronic acid infusion given. **S**

## Medication changes

- Started: Calcium carbonate 500 mg chewable tablet, one or two tablets by mouth as needed for heartburn, no more than six tablets a day, while off omeprazole before the endoscopy **S**
- Started: Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a year **S**

## Guideline basis

- EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801 (2006), European Federation of Neurological Societies
- Review of the anaesthetic management of patients with post-polio syndrome. Br J Anaesth 2025;134(5):1385-1391 (2025), British Journal of Anaesthesia
- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2022;117(1):27-56 (2022), American College of Gastroenterology
- RECLAST (zoledronic acid) injection: prescribing information (acute phase reaction, calcium and kidney checks, osteonecrosis of the jaw) (2026), U.S. National Library of Medicine, DailyMed
- CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026), Aether Forge

## Follow-up

- Endoscopy in about ten days. Call if fever or aching after the infusion. Primary care review with the endoscopy result. **S**
- Next scheduled visit 1957-05-18: endoscopy results and reflux treatment; post-polio syndrome follow-up. **S**
